These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thymectomy as treatment of autoimmune diseases other than myasthenia gravis. D'Andrea V; Malinovsky L; Ambrogi V; Artico M; Capuano LG; Buccolini F; De Antoni E Thymus; 1993 Feb; 21(1):1-10. PubMed ID: 8480342 [TBL] [Abstract][Full Text] [Related]
4. [Clinico-immunologic parallels in evaluating the treatment of multiple sclerosis]. Chernigovskaia NV; Ogurtsov RP; Matveeva TS; Popov VG; Puzyreva VP Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):24-8. PubMed ID: 2160163 [TBL] [Abstract][Full Text] [Related]
5. [Changes in the immunological reactivity of patients with disseminated sclerosis treated by prednisolone and the preparation Proper-Myl]. Iarosh AA; Macheret EL; Iarosh AA; Zapadniuk BV Vrach Delo; 1990 Feb; (2):83-6. PubMed ID: 2339565 [TBL] [Abstract][Full Text] [Related]
7. [Clinical aspects of the therapy of autoimmune disorders using serotonin]. Abramchik GV; Leonovich AL; Ulashchik VS; Starostenko LI; Tanina RM Fiziol Cheloveka; 1984; 10(2):255-9. PubMed ID: 6532837 [No Abstract] [Full Text] [Related]
8. Potassium channels, memory T cells, and multiple sclerosis. Beeton C; Chandy KG Neuroscientist; 2005 Dec; 11(6):550-62. PubMed ID: 16282596 [TBL] [Abstract][Full Text] [Related]
9. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy]. MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111 [No Abstract] [Full Text] [Related]
10. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients]. Matveeva TV; D'iakonova IN; Shaĭdullina FS Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132 [TBL] [Abstract][Full Text] [Related]
11. [The significance of a natural inhibitory factor in the pathogenesis of disseminated sclerosis]. Dziuba AN; Frolov VM; Peresadin NA Lik Sprava; 1993; (2-3):93-5. PubMed ID: 8191750 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus in the development of multiple sclerosis. Ascherio A Expert Rev Neurother; 2008 Mar; 8(3):331-3. PubMed ID: 18345964 [No Abstract] [Full Text] [Related]
13. [Use of hemosorption in disseminated sclerosis]. Golovkin VI; Pershin VN; Tulenko AG Vrach Delo; 1986 Feb; (2):84-6. PubMed ID: 3486528 [No Abstract] [Full Text] [Related]
14. Autoimmune diseases. The B cell slayer. Matthews R Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858 [No Abstract] [Full Text] [Related]
15. Copolymer 1 from the laboratory to FDA. Teitelbaum D; Sela M; Arnon R Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880 [No Abstract] [Full Text] [Related]
16. [Role of immune mechanisms in the pathogenesis of disseminated sclerosis]. D'iakonova IN; Matveeva TV Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):66-70. PubMed ID: 6979141 [No Abstract] [Full Text] [Related]
17. [Clinico-immunologic correlations in disseminated sclerosis]. Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842 [TBL] [Abstract][Full Text] [Related]
18. Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model. McFarland HF J Clin Invest; 1994 Sep; 94(3):921-2. PubMed ID: 8083376 [No Abstract] [Full Text] [Related]
19. [Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone]. Iarosh AA; Tiazhkorob AM; Prokopiv MM; Kanevskaia SA; Zhovnir IK Vrach Delo; 1991 Dec; (12):61-3. PubMed ID: 1792777 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the T cell receptor V gene usage in multiple sclerosis and human autoimmune thyroiditis. Ben-Nun A; Bach MA; Raus J; Davies TF Isr J Med Sci; 1993; 29(2-3):164-7. PubMed ID: 8468172 [No Abstract] [Full Text] [Related] [Next] [New Search]